Description
GLP-1 SEMA is a long-acting GLP-1 receptor agonist modeled after Semaglutide, a compound extensively studied for its powerful metabolic effects. As a GLP-1 analog, it simulates the body’s natural incretin hormone to help regulate blood glucose levels, enhance insulin secretion, slow gastric emptying, and reduce appetite.
In research settings, GLP-1 SEMA is being evaluated for its potential to:
-
Improve insulin sensitivity and glycemic control
-
Reduce body weight by suppressing appetite and calorie intake
-
Delay gastric emptying for better post-meal glucose regulation
-
Support cardiovascular and metabolic health
Due to its potency and prolonged activity, GLP-1 SEMA is intended for research use only and is not approved for human consumption. It is a valuable tool in the study of type 2 diabetes, obesity, and related metabolic disorders.
There are no reviews yet.